Disclosure: Some links on this site are affiliate links. If you purchase through these links, we may earn a commission at no extra cost to you. Thank you for supporting our site.·For informational purposes only—not medical advice.
Fact-checked against primary sources (FDA.gov, provider websites, Trustpilot, NEJM clinical trials)
MEDVi vs Hers: Which GLP-1 Weight Loss Program Is Actually Better in 2026?
Short version: MEDVi is still the better fit if you want the lower-commitment, compounded-first path and don't want to prepay a long medication plan. Hers is the better fit if you want a polished app, a required Weight Loss Membership, and easier access to current brand-name options like Wegovy® pill, Wegovy® pen, and Ozempic®.
Most comparison pages stop there. We didn't. We verified pricing from both providers' official sites, audited 18,000+ combined Trustpilot reviews, checked FDA enforcement databases, confirmed pharmacy partnerships, and reviewed cancellation and refund policies word by word. Below is everything we found — no fluff, no spin, just verified data so you can decide for yourself.
MEDVi vs Hers at a Glance
Every row below was verified against each provider's official website. Where we couldn't confirm a claim, we say so.
| Feature | MEDVi | Hers |
|---|---|---|
| Best For | Lower-commitment compounded-first path, month-to-month billing | Best app-based, brand-name-first membership experience |
| First Month | $179 | Varies by medication path. Current official pages show Wegovy® pill from $149/mo, Wegovy® pen and Ozempic® from $199/mo, generic liraglutide from $299/mo — all with a required membership billed separately. |
| Ongoing Cost | $299/mo (all-inclusive compounded path) | Medication pricing plus a required Weight Loss Membership; older official Hers materials still reference compounded semaglutide multi-month plans. Verify at checkout. |
| Upfront Payment | $179 only | Depends on the medication path and checkout flow. Do not assume a single universal starting point. |
| Contract | None — month-to-month | Monthly Weight Loss Membership + auto-renewing Medication Plan; some official Hers materials still reference 2-, 4-, and 6-month GLP-1 plans. |
| Compounded Semaglutide | Yes (injectable + dissolvable tablets) | Yes (injectable) |
| Compounded Tirzepatide | Yes (starts at $349 injectable, $279 tablets) | No (brand-name only) |
| Brand-Name Meds | Compounded core program + current product pages also list Wegovy® pill, Wegovy® injection, and Zepbound® injection as separate routes | Yes (Wegovy® pill, Wegovy® pen, Ozempic®, Mounjaro®, Zepbound®, generic liraglutide) |
| Non-GLP-1 Meds | No | Yes (metformin, bupropion/naltrexone, etc.) |
| Trustpilot | 4.4/5 (11,510 reviews) | 3.4/5 (6,921 reviews) |
| Clinical Support | 24/7 support, unlimited appointments, messaging with licensed providers | Unlimited support from a dedicated Care Team, in-app tracking, dosage adjustments, unlimited provider messaging |
| Mobile App | No (patient portal via browser) | Yes (iOS + Android) |
| LegitScript Certified | Yes | Yes |
| FDA Warning Letters | Feb. 20, 2026 warning letter | Sept. 9, 2025 warning letter |
| States | Most states (confirm during eligibility check) | Most states (varies by medication) |
| HSA/FSA | Accepted | Accepted |
| Cancellation | 72 hours notice, no penalty | Cancel anytime, but no refund for prepaid months |
| Money-Back / Refunds | Current published policy: refund only if medically disqualified. Ordinary cancellation does not qualify for a refund. | Initial Medication Plan refundable within 48 hrs of payment only. No refund for partially used Membership or Medication Plan periods. |
| Pharmacy Partners | Licensed U.S. compounding pharmacies | Licensed U.S. compounding pharmacies |
All data verified March 30, 2026. Pricing and policies may change — verify directly with each provider before purchasing.
Pick MEDVi If…
This is your first time trying GLP-1
$179 to start is the lowest-risk entry point. If the medication doesn't agree with you (nausea is common in weeks 1-3), you haven't locked yourself into $1,194. You can cancel before month 2 with 72 hours notice.
You want tirzepatide as a backup option
If compounded semaglutide doesn't produce results, MEDVi can switch you to compounded tirzepatide (a dual GLP-1/GIP agonist). Hers does not offer compounded tirzepatide.
You want lower-commitment compounded-first care with stronger review depth
MEDVi now has 11,510 Trustpilot reviews with a 4.4 TrustScore — notably higher than Hers (3.4/5). Its current site also markets 24/7 support and unlimited appointments. Multiple reviews specifically praise response times and provider accessibility.
You live in a state Hers doesn't serve
MEDVi is available in most U.S. states (confirm during the eligibility check). Hers states its weight loss treatment is not available in all 50 states, and availability varies by medication.
You want lower financial downside if you stop early
MEDVi's compounded path is still month-to-month, which lowers your financial exposure versus a long prepaid medication plan. Note: ordinary cancellation does not qualify for a refund under MEDVi's current published policy, but your total out-of-pocket still stays limited to months you've actually used.
MEDVi
$179 first month, then $299/mo
Pick Hers If…
You want the cleanest app-based, brand-name-first path
Hers now foregrounds Wegovy® pill, Wegovy® pen, and Ozempic® on its current weight-loss pages, plus Mounjaro®, Zepbound®, and generic liraglutide. It layers those medication options on top of a Weight Loss Membership that includes a dedicated Care Team, unlimited support, in-app tracking, and dosage adjustments.
You want FDA-approved oral or injectable semaglutide from the same platform
Hers currently offers Wegovy® pill (oral semaglutide) and Wegovy® pen (injectable semaglutide) alongside Ozempic®, Mounjaro®, and Zepbound® — all via the same platform and Care Team. MEDVi's current product pages also list branded options, but the compounded path remains its core offering.
You want an app-based experience
Hers has a polished mobile app for managing prescriptions, messaging providers, and tracking progress. MEDVi uses a browser-based patient portal — functional but not as slick.
You want non-GLP-1 oral medications first
Hers offers metformin, bupropion/naltrexone, and other non-injectable weight loss medications. If you want to try oral-only options before committing to GLP-1 injectables, Hers gives you that flexibility. MEDVi is GLP-1 focused.
You prefer a publicly traded company
Hers (parent company Hims & Hers Health, NYSE: HIMS) is a publicly traded company with SEC reporting obligations, quarterly earnings calls, and external auditing. Some people find this level of transparency reassuring. MEDVi is privately held.
Hers
Wegovy® pill from $149/mo + membership
Real Cost Comparison: What You Actually Pay
Hers no longer has one clean public price story. Current official Hers pages show medication pricing plus a required Weight Loss Membership ($39 for the first month and $149/month thereafter, per current public materials), while older official Hers materials still reference compounded semaglutide starting at $199/month and note 2-, 4-, and 6-month GLP-1 plan options. MEDVi is still simpler on the compounded path.
MEDVi Pricing
| Medication | First Month | Ongoing/Month |
|---|---|---|
| Compounded Semaglutide (Injectable) | $179 | $299/mo (MEDVi states refills locked at $299) |
| Compounded Semaglutide (Dissolvable Tablets) | Starts at $249 | Varies by dose/pharmacy; confirm at checkout |
| Compounded Tirzepatide (Injectable) | Starts at $349 | Varies by dose/pharmacy; confirm at checkout |
| Compounded Tirzepatide (Dissolvable Tablets) | Starts at $279 | Varies by dose/pharmacy; confirm at checkout |
| Wegovy® pill / Wegovy® injection / Zepbound® injection | Requires $99/mo membership + medication cost | Verify at checkout; pricing varies by medication and dose |
(Verified March 30, 2026 from glp.medvi.org. Older MEDVi public pages also still show tirzepatide and Ozempic pricing at different rates — MEDVi's public web properties are not fully synchronized; verify at checkout.)
Hers Pricing
Because Hers's current public materials are not fully synchronized, do not anchor on one universal Hers price. The table below reflects what is currently visible on official Hers pages — verify at checkout before purchasing.
| Medication | Per-Month Rate (Current Main Pages) | Notes |
|---|---|---|
| Wegovy® pill (oral semaglutide) | From $149/mo | Weight Loss Membership required and billed separately |
| Wegovy® pen / Ozempic® | From $199/mo | Weight Loss Membership required and billed separately |
| Generic Liraglutide | From $299/mo | Weight Loss Membership required and billed separately |
| Mounjaro® / Zepbound® | $1,899/mo | Cash pay; older Hers materials also still reference compounded semaglutide multi-month plans |
| Non-GLP-1 oral options (metformin, bupropion-naltrexone) | From $69/mo | Verify current plan structure at checkout |
(Verified March 30, 2026 from forhers.com/weight-loss and forhers.com. Current Hers pricing is subject to change; verify directly at checkout.)
The Bottom Line on Cost
MEDVi is simpler to price: $179 first month, $299/mo compounded path, month-to-month. Hers pricing depends on which medication path and membership structure applies to your checkout flow — do not assume a single universal starting price. Most first-time GLP-1 users benefit from MEDVi's month-to-month structure because it limits downside if the medication isn't a fit.
Illustrative comparison. Verify current pricing directly with each provider.
Want month-to-month flexibility?
Start MEDVi — compounded plans from $179Want brand-name options?
Check Hers membership & medication optionsWhat Medication Do You Actually Get?
The medication story for both platforms has broadened significantly since 2025. MEDVi's current product page shows compounded injections and tablets plus Wegovy® pill, Wegovy® injection, and Zepbound® injection as separate routes. Hers's current main weight-loss pages foreground Wegovy® pill, Wegovy® pen, Ozempic®, Mounjaro®, Zepbound®, and generic liraglutide, while older official Hers materials still reference compounded semaglutide plans. The FDA has stated that compounded drugs should not be marketed as equivalent to FDA-approved products. Compounded products have not undergone separate FDA clinical trials as finished products.
For educational purposes. Not medical advice.
MEDVi Medication Options
- Compounded GLP-1 injections — weekly subcutaneous injection; the compounded path starts at $179/mo first month
- Compounded GLP-1 tablets — daily dissolvable tablet, needle-free option. See our MEDVi pills review.
- Wegovy® pill — FDA-approved oral semaglutide, available via MEDVi's $99/mo membership route
- Wegovy® injection — FDA-approved injectable semaglutide, available via MEDVi's $99/mo membership route
- Zepbound® injection — FDA-approved tirzepatide, available via MEDVi's $99/mo membership route
- Compounded tirzepatide — injections starting at $349/mo or tablets starting at $279/mo. See our MEDVi tirzepatide review.
Note: Older MEDVi public pages also still show tirzepatide and Ozempic pricing at different rates. MEDVi's public web properties are not perfectly synchronized; verify exact availability and pricing in checkout.
Hers Medication Options
- Wegovy® pill — oral semaglutide, from $149/mo on current main Hers pages; Weight Loss Membership required separately
- Wegovy® pen — injectable semaglutide, from $199/mo; Weight Loss Membership required separately
- Ozempic® — from $199/mo; Weight Loss Membership required separately
- Mounjaro® / Zepbound® — brand-name tirzepatide at cash pricing (~$1,899/mo)
- Generic liraglutide — from $299/mo; Weight Loss Membership required separately
- Metformin, bupropion/naltrexone — oral non-GLP-1 options
Note: Older official Hers materials still reference compounded semaglutide starting at $199/mo and mention 2-, 4-, and 6-month GLP-1 plan options. Verify current Hers pricing and plan structure at checkout.
Five Questions to Ask Before You Pay
- Is the medication FDA-approved as a finished product, or compounded?
- Which specific pharmacy compounds or dispenses the medication?
- What happens if I experience side effects — who do I contact?
- What is the exact cancellation policy and refund timeline?
- Are there any additional fees beyond the advertised price (shipping, consultation, supplies)?
Verify these with any GLP-1 telehealth provider before purchasing.
Is MEDVi Legit? Full Verification
We checked everything we could verify from public sources. Here's what we found.
What Checks Out
- LegitScript certified — independently verified as a legitimate telehealth platform
- Licensed pharmacy partners — medications dispensed by state-licensed U.S. compounding pharmacies
- Clinical network — prescriptions written by licensed U.S. healthcare providers
- 11,510 Trustpilot reviews averaging 4.4/5 — verified review volume
- Verifiable physical business presence
- 24/7 support and unlimited appointments marketed on current MEDVi product pages
What to Know
- FDA warning letter (Feb. 20, 2026) — MEDVi received a warning letter regarding false or misleading marketing claims about compounded semaglutide and tirzepatide products. This was a marketing language issue, not a safety recall or product seizure.
- Shipping delays reported — some patients report 5-9 business day waits for initial shipments
- Occasional billing hiccups — a small number of reviews mention unexpected charges or billing timing confusion
Is Hers Legit?
- Publicly traded (NYSE: HIMS) — SEC reporting, quarterly earnings, external audits
- LegitScript certified
- September 2025 FDA warning letter — regarding marketing claims on certain products
- February 2026 product withdrawal — Hers pulled a $49 compounded semaglutide product from its platform
How to Spot a Scam Provider (6 Red Flags)
- No verifiable pharmacy — they can't name the pharmacy that fills prescriptions
- No LegitScript certification — any legitimate telehealth platform should have this
- "FDA-approved" claims about compounded meds — compounded drugs are NOT FDA-approved as finished products
- No licensed provider review — medication shipped without a real doctor or NP evaluating you
- Pricing too good to be true — if compounded semaglutide is under $100/mo, investigate further
- No clear cancellation policy — if you can't find how to cancel before signing up, don't sign up
Is MEDVi FDA-Approved? Is Hers?
This question gets asked constantly, and the answer is more nuanced than "yes" or "no."
| What's Being Asked | MEDVi | Hers |
|---|---|---|
| Is the platform FDA-approved? | No (FDA doesn't approve telehealth platforms) | No (same reason) |
| Are the medications FDA-approved? | Brand-name Wegovy and Zepbound are FDA-approved drugs. Compounded GLP-1 products are not FDA-approved. | Same — brand-name drugs are FDA-approved; compounded products are not |
| Does the platform have FDA warning letters? | Yes (Feb. 20, 2026) | Yes (Sept. 9, 2025) |
The tradeoff: Compounded GLP-1 medications cost a fraction of brand-name ($179-$299/mo vs $1,300+/mo for Wegovy without insurance). The tradeoff is that you're getting a pharmacy-compounded product that hasn't gone through the same FDA approval process as the brand-name version. For more on this, read our full guide: Is Compounded Semaglutide Safe?
Important 2026 update: Both MEDVi and Hers now have FDA warning letters. This page should no longer frame FDA marketing scrutiny as a Hers-only issue. MEDVi received its warning letter on February 20, 2026 (regarding compounded product marketing language); Hers received its on September 9, 2025. Neither letter involved product seizures, safety recalls, or injunctions.
How Does MEDVi Work? (Step by Step)
MEDVi: 5 Steps
- Complete the intake form — Medical questionnaire about your health history, medications, and weight loss goals (10-15 minutes)
- First month is charged — MEDVi's current policy states the first month is charged when the intake form is completed, before clinician review
- Clinician review — A licensed healthcare provider reviews your assessment and determines if you're eligible for treatment
- Prescription and delivery — If appropriate, medication is prescribed and shipped directly to your door in temperature-controlled packaging (5-9 business days typical for first order)
- Ongoing support — 24/7 support, unlimited appointments, and messaging continue through your subscription; refill monthly with no contract
General telehealth process illustration. Provider-specific steps may vary.
Hers: 5 Steps
- Download the app or visit the website — Create an account and select a weight loss category
- Complete the intake form — Health questionnaire and photo upload (more automated than MEDVi)
- Provider match — Hers assigns you a provider who reviews your intake and selects a treatment
- Choose your plan and pay — Select a 3-month or 6-month plan and pay the full amount upfront
- Receive medication and track via app — Use the Hers app for progress tracking, messaging, and prescription management
Key Process Difference
MEDVi is more provider-driven: a real clinician reviews your case and you pay month-to-month. Hers is more app-driven: a more automated intake funnels you into a prepaid plan. Neither approach is inherently better — it depends on whether you prefer human touch or digital convenience.
How to Cancel (The Honest Version)
Canceling MEDVi
- Billing: Month-to-month. No prepaid commitments.
- How: Contact MEDVi support at least 72 hours before your next billing date via the patient portal chat or [email protected].
- Penalty: None. No cancellation fee.
- Refunds: Current published policy is stricter than older marketing language suggested. Ordinary cancellation does not qualify for a refund. Refunds apply only if you are medically disqualified from the program. See full terms at home.medvi.org/cancellation-and-refund-policy.
Canceling Hers
- Billing: Weight Loss Membership renews monthly; Medication Plan also auto-renews. Both require cancellation at least 2 days before the next billing date.
- How: Cancel through the Hers app or website. Both the Membership and Medication Plan must be canceled separately.
- Multi-month plan timing: If medication was pre-shipped for a multi-month plan, cancellation timing follows the next billing date after the currently shipped supply.
- Refunds: Initial Medication Plan orders are refundable only if canceled within 48 hours of submitting payment. No refund for partially used Membership or Medication Plan periods. No refund for medication after it has shipped.
"Protect Yourself" Checklist
- Screenshot your subscription terms before you pay — including cancellation and refund policies
- Set a calendar reminder 4 days before your billing date if you're considering canceling
- Get written confirmation of any cancellation (email or in-app message)
- Start monthly if this is your first GLP-1 experience — upgrade to a longer plan only after you know the medication works for you
Customer Reviews: What Real Patients Say
MEDVi Reviews: 4.4/5 on Trustpilot (11,510 reviews)
MEDVi's review volume and rating are both strong relative to the telehealth weight loss space.
What MEDVi reviewers consistently praise:
- Fast approval process (commonly reported within 24-48 hours)
- Responsive provider communication and same-day support replies
- Dissolvable tablet option appreciated by needle-averse patients
- Noticeable weight loss results reported within 1-4 months
What MEDVi reviewers consistently flag:
- First shipment can take 5-9 business days (subsequent refills are faster)
- Some billing timing confusion reported
- Limited to GLP-1 medications only (no metformin or other weight loss drugs)
Themes identified from analysis of Trustpilot reviews. Individual experiences vary.
Common MEDVi complaints: Shipping delays on first orders (5-9 days), occasional billing timing confusion, and limited non-GLP-1 options.
Hers Reviews: 3.4/5 on Trustpilot (6,921 reviews)
Hers' lower rating is driven by three recurring complaint themes:
- Refund frustrations — Patients who cancel prepaid plans report difficulty getting refunds for unused months
- Medication switches without warning — Some patients report being switched to different formulations or dosages without adequate communication
- Customer support responsiveness — Wait times for support responses cited as a common frustration
Reddit mentions: Both providers are discussed on r/semaglutide and r/tirzepatide. MEDVi generally receives more positive mentions regarding provider responsiveness. Hers receives more discussion about pricing structure and the app experience. Take all Reddit anecdotes in context.
Individual results vary. Reviews reflect personal experiences and may not represent typical outcomes. Always discuss treatment options with a licensed healthcare provider.
How Effective Are GLP-1 Medications?
The effectiveness data comes from clinical trials of the FDA-approved brand-name versions, not the compounded versions prescribed by MEDVi or Hers. We include these because they're the best available evidence for the active ingredients both platforms use.
STEP 1 Trial (Semaglutide)
- Participants on semaglutide 2.4 mg lost an average of 14.9% of body weight over 68 weeks
- 86.4% lost at least 5% of body weight; 69.1% lost at least 10%
- Source: Wilding et al., New England Journal of Medicine, 2021
SURMOUNT-1 Trial (Tirzepatide)
- Participants on tirzepatide 15 mg lost an average of 20.9% of body weight over 72 weeks
- 91% achieved at least 5% weight reduction; 57% achieved at least 20%
- Source: Jastreboff et al., New England Journal of Medicine, 2022
Real Telehealth Patient Reports
Patients using telehealth platforms like MEDVi and Hers commonly report noticeable appetite reduction within 2-4 weeks and visible weight loss by weeks 4-8. Many report losing 10-30+ pounds over 3-6 months. However, individual results vary significantly based on starting weight, dosage, diet, activity level, and individual biology.
Honest Reality Check
Clinical trial results represent averages from controlled settings. Your results on compounded GLP-1 medications may differ from brand-name trial data. The compounded versions have not been independently tested in the same large-scale trials. That said, compounded GLP-1 medications are intended to produce similar therapeutic effects, and telehealth patient reports are broadly consistent with clinical trial outcomes.
Side Effects & Who Should NOT Take GLP-1 Medications
Common Side Effects
The percentages below are from Wegovy (semaglutide) adult clinical trials; side-effect rates differ for tirzepatide and by dose. These affect users regardless of whether you get medication through MEDVi, Hers, or any other provider:
- Nausea (most common, affects ~44% in clinical trials)
- Diarrhea (~30%)
- Vomiting (~24%)
- Constipation (~24%)
- Abdominal pain (~20%)
- Headache
- Fatigue
- Injection site reactions (for injectable forms)
These typically improve within 2-4 weeks. Gradual dose titration (starting low and increasing slowly) reduces severity. See our complete guide: GLP-1 side effect management.
Contact Your Provider Immediately If You Experience:
- Severe abdominal pain that doesn't go away
- Signs of pancreatitis (severe upper abdominal pain radiating to your back)
- Vision changes
- Signs of allergic reaction (difficulty breathing, facial swelling, rash)
- Signs of kidney problems (decreased urination, swelling)
- Gallbladder problems (upper right abdominal pain, fever, jaundice)
Who Should NOT Take GLP-1 Medications
- Personal or family history of medullary thyroid carcinoma (MTC)
- Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
- Known hypersensitivity to semaglutide, tirzepatide, or any product component
- Pregnancy or planning to become pregnant (discontinue at least 2 months before planned conception)
Source: FDA-approved prescribing information for Wegovy (semaglutide) and Zepbound (tirzepatide). This is not a complete list. Always discuss your full medical history with your prescribing provider.
What Changed With Compounded GLP-1s in 2025-2026
The compounded GLP-1 landscape has shifted significantly. Here's the timeline:
2022-2024: The Shortage Era
FDA-approved Wegovy and Ozempic faced severe shortages. Under the Drug Shortage Exception, compounding pharmacies were legally permitted to produce compounded semaglutide to fill the gap. Telehealth providers (including MEDVi) built their businesses during this period.
February 2025: FDA Declares Shortage Resolved
The FDA announced that the semaglutide shortage had been resolved, which technically removes the Drug Shortage Exception that allowed compounding. However, legal challenges and enforcement ambiguity continued.
2025–2026: Lawsuits and Enforcement Actions
Multiple telehealth providers and compounding pharmacies filed lawsuits challenging the FDA's position. Courts issued mixed rulings. The FDA sent 30+ warning letters to telehealth companies over misleading compounded GLP-1 marketing (March 2026). Compounded semaglutide remains available through many providers while legal proceedings continue.
April–May 2026: Current Status
MEDVi still clearly markets compounded GLP-1 injections and tablets as of May 2026. Hers's current main pages foreground brand-name options; older Hers materials still reference compounded plans. Important regulatory note: 503A pharmacies generally fill patient-specific prescriptions. For semaglutide and tirzepatide, the FDA has stated those substances are not currently on the 503B bulks list or FDA shortage list — do not treat “503B” alone as proof that a compounded GLP-1 is FDA-approved or legally available.
What This Means for You
- MEDVi still clearly markets compounded semaglutide as of May 2026. Hers's current main pages foreground brand-name options, though older Hers materials still reference compounded plans.
- The regulatory landscape could change — a court ruling or FDA enforcement action could affect compounded availability for either provider
- Month-to-month billing is safer if availability changes — you're not locked into a prepaid plan for a medication that might be pulled
- MEDVi's older public pages still list tirzepatide pricing, but MEDVi's public web properties are not perfectly synchronized. Keep tirzepatide availability as something to verify in checkout, not a blanket guaranteed backup.
The One MEDVi Downside Nobody Talks About
$299/month is real money. Over 12 months, that's $3,468. It's not pocket change, and we won't pretend otherwise.
But context matters: brand-name Wegovy costs $1,300+ per month without insurance. Brand-name Zepbound costs similarly. MEDVi's $299/mo for compounded semaglutide is roughly 77% less than the brand-name alternative.
The question isn't whether $299/mo is expensive in absolute terms — it is. The question is whether it's worth it relative to your alternatives and your health goals.
Compounded Tirzepatide Availability
| Tirzepatide Option | MEDVi | Hers |
|---|---|---|
| Compounded tirzepatide injections | Starts at $349/mo (confirm ongoing rate at checkout) | Not available |
| Compounded tirzepatide tablets | Starts at $279/mo (confirm ongoing rate at checkout) | Not available |
This is a significant differentiator. Tirzepatide (the active ingredient in Zepbound and Mounjaro) is a dual GLP-1/GIP receptor agonist that produced 20.9% average body weight loss in the SURMOUNT-1 trial — versus 14.9% for semaglutide. If semaglutide isn't producing adequate results, having the option to switch to tirzepatide without changing providers is a meaningful advantage for MEDVi. Read our full review: MEDVi Tirzepatide Reviews.
Insurance, HSA, and FSA
Neither MEDVi nor Hers accepts insurance for their compounded GLP-1 programs. Both are cash-pay (out-of-pocket) only. This is typical for compounded medication telehealth providers — insurance plans generally don't cover compounded drugs.
Both accept HSA and FSA payments. GLP-1 weight loss treatment generally qualifies as a medical expense under most HSA/FSA plans, but check with your plan administrator to confirm eligibility before relying on this.
State Availability
State availability varies. Hers states its weight loss treatment is not available in all 50 states, and you'll see eligibility during signup. MEDVi does not publish a public state list; confirm availability through the MEDVi eligibility check or by contacting their support team. Specific medication availability may also vary by state due to compounding pharmacy licensing.
Final Decision Framework: MEDVi vs Hers
Simplified decision framework. Your situation may involve additional factors.
| If this sounds like you… | Choose | Because |
|---|---|---|
| First time trying GLP-1 medication | MEDVi | $179 entry point, month-to-month, lowest financial risk |
| Want the lower-commitment compounded-first route | MEDVi | Month-to-month billing limits your exposure; compounded path is still MEDVi's core |
| Needle-phobic, want oral options | MEDVi | Dissolvable tablets for both compounded semaglutide and tirzepatide |
| Want non-GLP-1 options first | Hers | Offers metformin, bupropion/naltrexone as first-line options |
| Need 24/7 support and month-to-month compounded pricing | MEDVi | Current MEDVi site markets 24/7 support and unlimited appointments |
| Want Wegovy® pill, Wegovy® pen, or Ozempic® inside a polished app | Hers | Hers foregrounds brand-name options + dedicated Care Team + mobile app |
| Want the clearest brand-name/app-based membership route | Hers | Hers Weight Loss Membership bundles brand-name access with Care Team support |
| Want a publicly traded company | Hers | NYSE: HIMS with SEC reporting obligations |
| Care most about avoiding long prepaid medication-plan exposure | MEDVi | Month-to-month compounded path vs Hers membership structure |
If you're still unsure: Start with MEDVi.
The month-to-month billing means your maximum downside is $179 for the first month. If the medication works and the experience is good, you can stay. If not, you can switch to Hers (or anywhere else) without losing hundreds of dollars on a prepaid plan you didn't finish.
Alternatives to MEDVi and Hers
MEDVi and Hers aren't your only options. Here are other providers worth considering, plus the traditional route through your own doctor. For a full comparison, see our best GLP-1 telehealth providers guide. If you're interested in other MEDVi comparisons, we also have MEDVi vs Zepbound and MEDVi vs Yucca Health comparisons.
Yucca Health
Compounded semaglutide from $206/mo with no membership fees, a welcome call, and responsive human support. 4.6/5 Trustpilot rating (720+ reviews). Good option if you want a strong support experience at a competitive price.
TrimRx
Another compounded GLP-1 telehealth provider with competitive pricing and both semaglutide and tirzepatide options. Compare their current offerings directly against MEDVi and Hers. See our TrimRx review.
Your PCP + Brand-Name Medication
If you have strong insurance coverage, getting FDA-approved Wegovy or Zepbound through your primary care physician may be the best route. Brand-name medications cost $1,300+/mo at retail but can be much less with insurance. You get the full FDA-approved product, in-person monitoring, and your existing medical team managing your care.
Quick Comparison: All Options
| Provider | Starting Price | Tirzepatide? | Contract | Best For |
|---|---|---|---|---|
| MEDVi | $179 first month | Yes | Month-to-month | Lowest-risk first try |
| Hers | $199/mo (6-mo plan) | Brand-name only | Prepaid (3 or 6 mo) | Committed long-term |
| Yucca Health | $206/mo | Yes | Month-to-month | Human support focus |
| TrimRx | Varies | Yes | Varies | Alternative option |
| Your PCP | $1,300+/mo (brand-name) | Yes (brand-name) | None | Insurance coverage |
Frequently Asked Questions: MEDVi vs Hers
Is MEDVi cheaper than Hers?
Not universally anymore. MEDVi's compounded path is simpler and lower-commitment: $179 first month, $299/mo ongoing, month-to-month. Hers now uses a required Weight Loss Membership plus separate medication pricing on its current main pages, while older official Hers materials still reference multi-month compounded semaglutide plans starting at $199/mo. Verify current Hers pricing at checkout before comparing.
Is MEDVi better than Hers for weight loss?
Neither platform is "better" in the abstract — outcomes depend on the medication, your adherence, and your individual biology. MEDVi is a better fit if you want a lower-commitment compounded-first route with month-to-month billing. Hers is a better fit if you want a polished app, a dedicated Care Team, and easier access to current brand-name options like Wegovy® pill, Wegovy® pen, and Ozempic®.
Is the semaglutide from MEDVi the same as Wegovy?
No. MEDVi prescribes compounded semaglutide, which is prepared by a licensed compounding pharmacy to produce a similar therapeutic effect. Compounded semaglutide has NOT undergone separate FDA clinical trials as a finished product. Wegovy is manufactured by Novo Nordisk and is FDA-approved.
Is MEDVi FDA-approved?
MEDVi as a telehealth platform is not FDA-approved (the FDA does not approve telehealth platforms). The medications MEDVi prescribes are compounded GLP-1 products prepared by licensed compounding pharmacies. Compounded drugs are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality.
Is MEDVi a scam?
No. MEDVi is a legitimate telehealth company with LegitScript certification, licensed pharmacy partners, 11,510+ Trustpilot reviews averaging 4.4/5, and a verifiable physical business presence. Note: MEDVi did receive an FDA warning letter dated February 20, 2026 regarding marketing language about compounded semaglutide and tirzepatide products — this was a marketing issue, not a safety recall.
Can I use HSA or FSA to pay for MEDVi or Hers?
Yes, both MEDVi and Hers accept HSA and FSA payments. Eligibility depends on your specific plan administrator's rules, but GLP-1 weight loss treatment generally qualifies as a medical expense under most HSA/FSA plans.
How do I cancel MEDVi?
Contact MEDVi support at least 72 hours before your next billing date via the patient portal chat or at [email protected]. No cancellation fee, no contract penalty. Important: ordinary cancellation does not qualify for a refund under MEDVi's current published policy. Refunds apply only if you are medically disqualified.
How do I cancel Hers?
Cancel through the Hers app or website at least 2 days before your next billing date — both the Weight Loss Membership and the Medication Plan renew separately and each requires 2-day advance cancellation. If medication was pre-shipped for a multi-month plan, cancellation timing follows the next billing date after the currently shipped supply. Initial Medication Plan orders are refundable only if canceled within 48 hours of submitting payment. No refunds for partially used Membership or Medication Plan periods, and no refund for medication after it has shipped.
What if my medication arrives warm?
Do NOT use it. Contact your provider immediately, document the packaging condition with photos, and request a replacement. Both MEDVi and Hers should replace compromised shipments at no additional charge. Injectable GLP-1 medications require cold-chain shipping.
What happens if semaglutide doesn't work for me?
With MEDVi, you can discuss switching to compounded tirzepatide (a dual GLP-1/GIP agonist that works on two hormone pathways). Hers does not currently offer compounded tirzepatide (though brand-name options are listed at higher prices). Both providers can adjust your dosage or treatment plan based on your response.
Can I switch from Hers to MEDVi?
Yes. Cancel your Hers subscription, then sign up with MEDVi. MEDVi will conduct their own medical evaluation — they won't just carry over your Hers prescription. The process typically takes 24-48 hours for approval.
How fast will I lose weight on GLP-1s?
In the STEP 1 clinical trial, participants on semaglutide lost an average of 14.9% of body weight over 68 weeks. Most people notice reduced appetite within 2-4 weeks, with visible weight loss starting around weeks 4-8. Individual results vary significantly.
What are the most common side effects?
Nausea (affecting ~44% of clinical trial participants), diarrhea (~30%), vomiting (~24%), constipation (~24%), and abdominal pain (~20%). These typically improve within 2-4 weeks as your body adjusts, especially when the dose is gradually increased.
Does Hers have an app?
Yes. Hers has a mobile app (iOS and Android) for managing prescriptions, messaging providers, tracking progress, and scheduling appointments. MEDVi does not currently have a dedicated mobile app but offers a patient portal accessible via mobile browser.
Is compounded semaglutide safe in 2026?
Compounded semaglutide is prepared by state-licensed compounding pharmacies to a prescriber's specification. It is not FDA-approved and has not undergone separate FDA review for safety, effectiveness, or quality as a finished product. The FDA has issued warnings about compounded GLP-1 products, noting that some may contain different salt forms than FDA-approved versions. Safety depends on the quality of the compounding pharmacy.
Does Hers have any FDA issues?
Yes. In September 2025, the FDA sent Hers a warning letter regarding marketing claims on certain products. In February 2026, Hers withdrew a $49 compounded semaglutide product from its platform. Hers remains operational and is publicly traded (NYSE: HIMS), but these are worth noting.
What does MEDVi's money-back guarantee cover?
MEDVi still uses guarantee language in some marketing materials, but the current published cancellation/refund policy is stricter: there is no guarantee of results or effectiveness, and ordinary cancellation does not qualify for a refund. Refunds apply if you are medically disqualified from the program. Read the full terms at home.medvi.org/cancellation-and-refund-policy before relying on any guarantee language.
MEDVi vs Yucca Health — which is better?
Yucca Health offers compounded semaglutide starting at $206/mo with no membership fees, a welcome call, and responsive human support. MEDVi is $179 first month, $299/mo ongoing. Yucca may be a better value for ongoing treatment; MEDVi offers a lower entry point and compounded tirzepatide as a backup.
MEDVi vs TrimRx — which is better?
TrimRx is another compounded GLP-1 telehealth provider. Both are legitimate options. Compare current pricing, medication availability, and cancellation terms directly. MEDVi's advantage is its money-back guarantee and tirzepatide availability.
How long does MEDVi shipping take?
MEDVi typically ships medication within 5-9 business days after prescription approval. First shipments may take slightly longer due to pharmacy processing. Subsequent refills are generally faster.
Does MEDVi offer a free consultation?
MEDVi's first month starts at $179, which includes the provider consultation, prescription, medication, and shipping. There is no separate consultation fee, but the consultation is part of the paid first month — not technically free.
Is Hers' $199/month price really $199?
Not as a single universal Hers price anymore. Current Hers main pages show medication pricing plus a required Weight Loss Membership billed separately, with options like Wegovy® pill from $149/mo, Wegovy® pen and Ozempic® from $199/mo, and generic liraglutide from $299/mo. Older official Hers materials still reference compounded semaglutide plans tied to 2-, 4-, and 6-month commitments. Verify current checkout pricing directly with Hers before purchasing.
Final Verdict: MEDVi vs Hers
MEDVi is still the better pick for most people who want a lower-commitment, compounded-first starting point. The month-to-month billing eliminates the biggest financial risk in GLP-1 telehealth, the $179 first month is the lowest-risk entry point available, and the 4.4/5 Trustpilot rating from 11,510 reviews signals genuine patient satisfaction. MEDVi's current product pages also now offer Wegovy® pill, Wegovy® injection, and Zepbound® injection as separate routes for those who want branded options later.
Hers is the better pick if you want a polished app, a required Weight Loss Membership, and easier access to current brand-name options like Wegovy® pill, Wegovy® pen, and Ozempic®. The most important shift in this comparison: Hers should no longer be framed as simply “$199/month six-month compounded semaglutide.” That was a cleaner framing a few months ago. It is not a clean March 2026 comparison anymore.
The safest move: start with MEDVi's compounded path (from $179), see how your body responds, then decide if you want to continue. If the medication works and you later decide you want brand-name options or a more app-centric Care Team experience, Hers remains a legitimate platform to evaluate at that point.
MEDVi
Compounded plans from $179 — no contract
Hers
Wegovy® pill from $149/mo + membership
How We Evaluated MEDVi vs Hers
Pricing Verification
All pricing was verified by visiting each provider's official website and documenting published prices. We did not rely on third-party pricing claims. Prices were last verified March 30, 2026.
Customer Satisfaction
Trustpilot ratings and review volumes were checked directly from Trustpilot.com. We read hundreds of individual reviews to identify common themes, not just the aggregate scores.
Regulatory Standing
We checked the FDA's Warning Letters database, Enforcement Actions database, and Drug Safety Communications for any actions involving either provider. We also verified LegitScript certification status for both platforms.
Recommendation Methodology
Our recommendations are based on the combination of pricing transparency, patient satisfaction data, regulatory compliance, medication availability, and cancellation flexibility. We do not recommend providers based solely on affiliate commission rates. Read our full methodology: How We Rank. For more educational content, visit our learning center.
About the WPG Research Team
This article was researched and written by the WPG Research Team. We compare GLP-1 telehealth providers based on pricing, policies, medication options, and user experience. Our comparison methodology prioritizes primary-source verification: we check provider websites, FDA databases, and third-party review platforms directly rather than relying on press releases or marketing claims. We do not provide medical advice. Our goal is to help readers make informed decisions by presenting verified, side-by-side comparisons using publicly available information and primary sources.
Sources
- MEDVi.org — Official website, pricing and program details (verified March 30, 2026)
- glp.medvi.org — MEDVi GLP-1 program landing page (verified March 30, 2026)
- MEDVi Cancellation & Refund Policy (verified March 30, 2026)
- ForHers.com — Official Hers website, pricing and plan details (verified March 30, 2026)
- Hers Terms and Conditions (verified March 30, 2026)
- Trustpilot — MEDVi Reviews (11,510 reviews, 4.4/5 average; verified March 30, 2026)
- Trustpilot — Hers Reviews (6,921 reviews, 3.4/5 average; verified March 30, 2026)
- Wilding JPH, Batterham RL, Calanna S, et al. "Once-Weekly Semaglutide in Adults with Overweight or Obesity." New England Journal of Medicine. 2021;384(11):989-1002. doi:10.1056/NEJMoa2032183
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. "Tirzepatide Once Weekly for the Treatment of Obesity." New England Journal of Medicine. 2022;387(3):205-216. doi:10.1056/NEJMoa2206038
- FDA.gov — FDA's Concerns About Unapproved GLP-1 Drugs Used for Weight Loss
- FDA.gov — Semaglutide Safety Information
- FDA — Wegovy (semaglutide) prescribing information
- FDA — Zepbound (tirzepatide) prescribing information
- FDA Warning Letters Database — Including MEDVi warning letter (Feb 20, 2026) and Hers warning letter (Sept 9, 2025)
- LegitScript.com — Telehealth certification verification
- SEC EDGAR — Hims & Hers Health (HIMS) SEC filings
- r/semaglutide — Community discussions on semaglutide providers
- r/tirzepatide — Community discussions on tirzepatide providers
- Rubino D, Abrahamsson N, Davies M, et al. "Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance." JAMA. 2021;325(14):1414-1425.
- Weight Loss Provider Guide — Is Compounded Semaglutide Safe?
- Weight Loss Provider Guide — MEDVi vs Ro Comparison
- Weight Loss Provider Guide — MEDVi vs Remedy Meds Comparison
- FDA.gov — FDA Intends to Take Action Against Non-FDA-Approved GLP-1 Drugs
Medical Disclaimer · Advertising Disclosure · Editorial Standards